Here we describe the cellular effects of the pharmacological inhibition of the checkpoint kinase Chk1 by the novel inhibitor V158411 in triple-negative breast cancer and ovarian cancer. The gene discussed is CHEK1; the disease is triple-negative breast carcinoma.